JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Uwe M. Fischer
Steven J. Allen
Uwe Mehlhorn
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fischer, U. M.
Right arrow Articles by Laine, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fischer, U. M.
Right arrow Articles by Laine, G. A.
Related Collections
Right arrow Myocardial protection

J Thorac Cardiovasc Surg 2003;126:1483-1488
© 2003 The American Association for Thoracic Surgery


Cardiopulmonary support and physiology

The antioxidant N-acetylcysteine preserves myocardial function and diminishes oxidative stress after cardioplegic arrest

Uwe M. Fischer, MDa,*, Charles S. Cox, Jr, MDa, Steven J. Allen, MDa, Randolph H. Stewart, PhDa, Uwe Mehlhorn, MDb, Glen A. Laine, PhDc

a Center for Microvascular and Lymphatic Studies, Department of Surgery and Anesthesiology, the University of Texas-Houston Medical School, Houston, Tex, USA
b Department of Thoracic and Cardiovascular Surgery, University of Cologne, Cologne, Germany
c Michael E. DeBakey Institute for Comparative Cardiovascular Science, Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Tex, USA

Received for publication July 26, 2002; revisions received September 4, 2002; accepted for publication March 11, 2003.

* Address for reprints: Uwe Fischer, MD, University of Cologne, Clinic for Cardiothoracic Surgery, Joseph-Stelzmann-Strasse 9, 50924 Köln, Germany
ufischer2000{at}hotmail.com

OBJECTIVE: Oxidative stress contributes to myocardial ischemia-reperfusion injury. We hypothesized that administration of the antioxidant N-acetylcysteine would have beneficial effects on myocardial function after cardiopulmonary bypass and cardioplegic arrest.

METHODS: Anesthetized dogs (n = 18) were instrumented with myocardial ultrasonic crystals and a left ventricular micromanometer. Systolic function was measured by preload recruitable stroke work. Myocardial tissue water was determined by microgravimetry. Treated animals received 100 mg · kg-1 N-acetylcysteine 10 minutes before initiation of cardiopulmonary bypass followed by 20 mg · kg-1 · h-1 continuous infusion until 1 hour after cardiopulmonary bypass. After baseline, cardiopulmonary bypass and 2-hour crystalloid cardioplegic arrest was initiated, then reperfusion/rewarming for 40 minutes and separation from cardiopulmonary bypass. Myocardial function parameters and myocardial tissue water were measured at 30, 60, and 120 minutes after cardiopulmonary bypass. Oxidative stress was measured by 8-isoprostane concentrations in the coronary sinus plasma.

RESULTS: Preload recruitable stroke work did not decrease from baseline in the N-acetylcysteine group and was significantly greater in N-acetylcysteine group compared with controls at 30 (104% ± 9% vs 80% ± 4%; P < .05) and 120 minutes (98% ± 7% vs 79% ± 4%; P < .05) after cardiopulmonary bypass. Concentrations of 8-isoprostane in the coronary sinus plasma of the control dogs were significantly higher 30 minutes after cardiopulmonary bypass compared with baseline but were unchanged in the N-acetylcysteine group. Myocardial edema resolution was significantly greater in the N-acetylcysteine group at 30 minutes after cardiopulmonary bypass compared with control (-2.5% ± 0.7% vs -0.3% ± 0.5% myocardial tissue water; P < .05).

CONCLUSIONS: Administration of the antioxidant N-acetylcysteine preserves systolic function and enhances myocardial edema resolution after cardiopulmonary bypass/cardioplegic arrest. Furthermore, oxidative stress was significantly reduced in the treated animals. Therefore, our findings support the hypothesis that oxidative stress is the main cause for myocardial dysfunction after ischemia-reperfusion.





This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Zhu, R. Yin, H. Shao, G. Dong, L. Luo, and H. Jing
N-acetylcysteine to ameliorate acute renal injury in a rat cardiopulmonary bypass model
J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 696 - 703.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
I. El-Hamamsy, L.-M. Stevens, M. Carrier, M. Pellerin, D. Bouchard, P. Demers, R. Cartier, P. Page, and L. P. Perrault
Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: A randomized, double-blind, placebo-controlled clinical trial
J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 7 - 12.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. B. Sharma, J. Sun, L. L. Howard, A. G. Williams Jr., and R. T. Mallet
Oxidative stress reversibly inactivates myocardial enzymes during cardiac arrest
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H198 - H206.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
U. M. Fischer, A. Antonyan, W. Bloch, and U. Mehlhorn
Impact of antioxidative treatment on nuclear factor kappa-B regulation during myocardial ischemia-reperfusion
Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 531 - 535.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. M. Knott, J. Sun, Y. Lei, M.-G. Ryou, A. H. Olivencia-Yurvati, and R. T. Mallet
Pyruvate Mitigates Oxidative Stress During Reperfusion of Cardioplegia-Arrested Myocardium.
Ann. Thorac. Surg., March 1, 2006; 81(3): 928 - 934.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. M. Knott, M.-G. Ryou, J. Sun, A. Heymann, A. B. Sharma, Y. Lei, M. Baig, R. T. Mallet, and A. H. Olivencia-Yurvati
Pyruvate-fortified cardioplegia suppresses oxidative stress and enhances phosphorylation potential of arrested myocardium
Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1123 - H1130.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Storti, A. G. Cerillo, A. Rizza, I. Giannelli, G. Fontani, M. Glauber, and A. Clerico
Coronary artery bypass grafting surgery is associated with a marked reduction in serum homocysteine and folate levels in the early postoperative period
Eur. J. Cardiothorac. Surg., October 1, 2004; 26(4): 682 - 686.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The American Association for Thoracic Surgery.